Tag: medtronic
EuroPCR 2026: SMART trial three-year data demonstrate superiority for Evolut TAVI system
Medtronic today relea...
Medtronic’s Endurant receives US FDA labelling approval to remove rAAA treatment warning
Medtronic recently an...
Advertorial: Newest-generation TAVI platforms designed to meet the demands of the modern cath lab
This advertorial is spons...
Advertorial: TAVI in small aortic annuli: SMART trial underscores importance of choosing the right device
This advertorial is spons...
Amazon executive joins Medtronic to spearhead development in robotics and implantables
Medtronic has announced t...
Medtronic launches Onyx Frontier coronary stent following CE mark approval
Medtronic has announced t...
Medtronic announces co-promotion agreement with CathWorks, with path toward acquisition
Medtronic today announced...
Medtronic names Laura Mauri as new chief scientific, medical and regulatory officer
Medtronic has announced t...
TCT 2021: Medtronic unveils data on hypertension treatment preferences, launches SPYRAL AFFIRM study
Medtronic has announced f...
SCAI 2020: Strong 10-year performance for Melody transcatheter pulmonary valve
A late-breaking clini...
COVID-19: Ventilator manufacturers unite to training alliance and create app for frontline workers
A press release reports t...
Targeted blood pressure management helps to reduce strokes in patients with HVAD
An analysis on the im...
ACC 2019: TAVI moves to the mainstream with new findings in low-risk patients
Evidence for the use of t...
CRT 2019: Evolut R superior to surgery at one year in intermediate-risk patients
A subanalysis from th...
US FDA approve study of CoreValve Evolut in low-risk patients with bicuspid valves
The US FDA has approv...
US FDA approval for SynchroMed II implantable system for treating pulmonary arterial hypertension
Medtronic has received US...
Use of Resolute Onyx to be explored for the treatment of bifurcation lesions
Medtronic has announc...
Medtronic appoints Laura Mauri as vice president, Global Clinical Research & Analytics
Medtronic has announced t...
Following FDA approval, Resolute Onyx 2mm becomes smallest stent on US market
Designed specifically...
“We really believe that the transradial approach is a better way to do cardiac catheterisations”
The Society for Cardi...
From SYMPLICITY HTN-1 to SPYRAL HTN-OFF MED: The story of renal denervation
It is now almost a de...
FORWARD PRO clinical study to evaluate longer term performance of CoreValve Evolut Pro
A new post-market cli...
ESC 2017: SPYRAL HTN-OFF MED provides “proof of principle” that renal denervation works
Results from SPYRAL H...
Medtronic to undertake global randomised clinical trial of one-month DAPT in Resolute Onyx patients
Medtronic has announc...
US FDA designates Medtronic HVAD system controller field action as class I recall
The US Food and Drug ...
Medtronic ENDURANCE Supplemental trial of HVAD fails to meet primary endpoint
Medtronic’s ENDURANCE...
Medtronic launches Impact education and development programme in Europe, Middle East & Africa
Medtronic has announced t...
Medtronic first to receive CE mark for less-invasive HVAD implant procedure
Medtronic’s HVAD syst...
TCT 2016: First-in-human data shows Medtronic’s drug-filled stent to be non-inferior to Resolute
Results of the REVELU...
FDA approval of 34mm CoreValve Evolut R means device is largest available TAVI valve in USA
Medtronic has announc...
Health Canada grants licence to Medtronic for its CoreValve Evolut R system
Medtronic Canada has ...
EACTS 2016: Positive one-year outcomes for Medtronic’s surgical aortic valve Avalus
Positive clinical data fo...
Medtronic ranks on Dow Jones Sustainability North America Index for ninth consecutive year
Medtronic has been re...
Renal denervation devices are alternatives to drug therapy, Technavio reports
Analysts from Technavio h...
